Recent Developments in Antiphospholipid Antibodies and the Antiphospholipid Syndrome

Rolf T. Urbanus

doi:10.1055/s-0038-1657761

Seminars in Thrombosis and Hemostasis, Table of Contents

Semin Thromb Hemost 2018; 44(05): 417-418
DOI: 10.1055/s-0038-1657761

Preface

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Recent Developments in Antiphospholipid Antibodies and the Antiphospholipid Syndrome

Authors

Rolf T. Urbanus

¹Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

Abstract

Full Text

References

References
1 Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken) 2013; 65 (11) 1869-1873
2 Cervera R, Piette JC, Font J. , et al; Euro-Phospholipid Project Group. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46 (04) 1019-1027
3 Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton III LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158 (06) 585-593
4 Rothwell PM, Coull AJ, Silver LE. , et al; Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366 (9499): 1773-1783
5 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (04) 692-699
6 Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621-622
7 Miyakis S, Lockshin MD, Atsumi T. , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (02) 295-306
8 Chighizola CB, Raimondo MG, Meroni PL. Management of thrombotic antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 419-426
9 Cohen H, Efthymiou M, Gates C, Isenberg D. Direct oral anticoagulants for thromboprophylaxis in patients with antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 427-438
10 Pengo V, Bison E, Denas G, Jose SP, Zoppellaro G, Banzato A. Laboratory diagnostics of antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 439-444
11 Molhoek JE, de Groot PG, Urbanus RT. The lupus anticoagulant paradox. Semin Thromb Hemost 2018; 44 (05) 445-452
12 Bertolaccini ML, Sanna G. The clinical relevance of noncriteria antiphospholipid antibodies. Semin Thromb Hemost 2018; 44 (05) 453-457
13 de Laat B, Derksen RH, Urbanus RT, de Groot PG. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood 2005; 105 (04) 1540-1545
14 Ioannou Y, Romay-Penabad Z, Pericleous C. , et al. In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept. J Thromb Haemost 2009; 7 (05) 833-842
15 Kelchtermans H, Chayoua W, Laat B. The significance of antibodies against domain I of beta-2 glycoprotein I in antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 458-465
16 Radin M, Cecchi I, Roccatello D, Meroni PL, Sciascia S. Prevalence and thrombotic risk assessment of anti-beta2 glycoprotein I domain I antibodies: a systematic review. Semin Thromb Hemost 2018; 44 (05) 466-474
17 Sacharidou A, Shaul PW, Mineo C. New insights in the pathophysiology of antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 475-482
18 Muller-Calleja N, Lackner KJ. Mechanisms of cellular activation in the antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 483-492
19 Chaturvedi S, Alluri R, McCrae KR. Extracellular vesicles in the antiphospholipid syndrome. Semin Thromb Hemost 2018; 44 (05) 493-504